Implementing Whole Blood Transfusion: Perspectives from Two Institutions

Please note: AABB reserves the right to make updates to this program.

Live Program Date: Wednesday, July 15, 2020 - On-Demand Available

Master Program Number: 20EL-553 (see program format numbers below under Registration)

Educational Track: Technical/Clinical
Topic: Transfusion Medicine
Intended Audience: Donor Recruitment Staff, Hospital Blood Banks, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Physicians, Residents/Fellows, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
Teaching Level: Intermediate

Director: Isabella W. Martin, MD, Assistant Professor of Pathology, Medical Director of Microbiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Moderator: Laura Nelson, MLS(ASCP)SBBcm, Testing Services Coordinator II, LifeServe Blood Center, Des Moines, IA
Speakers: Alyssa Ziman, MD, Professor, Pathology and Laboratory Medicine, Division Chief, Clinical Laboratory Medicine, Medical Director, Clinical Laboratories, Ronald Reagan UCLA Medical Center, Medical Director, Transfusion Medicine, UCLA Health, Los Angeles, CA; David Oh, MD, Chief Medical Officer, Hoxworth Blood Center, Medical Director, University of Cincinnati Medical Center, Program Director, Blood Banking/Transfusion Medicine Fellowship, Hoxworth Blood Center, Cincinnati, OH

Learning Objectives

After participating in this educational activity, participants should be able to:

  • Define how transfusion of whole blood differs from component-based therapy.
  • List decisions and challenges that may be faced in donor centers and laboratories when implementing whole blood transfusion.
  • Discuss the importance of interdisciplinary partnerships in implementation of whole blood transfusion.

Program Description

Transfusion of whole blood is currently a hot topic in the field of transfusion medicine. However, there are many decisions to make and challenges to face in regards to implementation of this type of blood product in civilian health care settings. In this eCast, medical directors at two institutions will describe their implementation process from a laboratory perspective with a special focus on the hurdles to implementation and how they can be overcome.

Registration

   Program #
Single Viewer: On-Demand Register20EL-553-4035
Group Viewing: On-Demand Register20EL-553-8035

Continuing Education Credit

AABB designates both the live and on-demand version of this eCast each eligible for 1 continuing education credits/contact hours for Physicians, General Participation, California Nurse, California Lab Personnel and Florida Lab Personnel. The number and type of credits awarded for this program (both live and on-demand) was determined by the program duration. For more information on each credit type please visit our Continuing Education Credits webpage.

Disclosures for the planners of this event can be found here. Disclosures for the program faculty are provided at the beginning of the program.

Speaker Biographies

Dr. David Oh Dr. David Oh is the Chief Medical Officer of Hoxworth Blood Center, University of Cincinnati. Dr. Oh is also Medical Director of the University of Cincinnati Medical Center. Dr. Oh is program director of the Blood Banking/Transfusion Medicine Fellowship at Hoxworth Blood Center. His areas of interest include blood center operations, whole blood utilization, and professional education.

Dr. Alyssa Ziman Dr. Alyssa Ziman is the Medical Director of Transfusion Medicine and Medical Director for the Ronald Reagan Clinical Laboratory at UCLA Health. Dr. Ziman is also Division Chief of Laboratory Medicine and a Clinical Professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA. Dr. Ziman’s research focuses on immunohematology, transfusion practice and patient safety, as well as donor safety and motivating factors in blood donors. In addition, she is a member of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative, an international research group.